Sexual Dimorphism of Immune Responses: A New Perspective in Cancer Immunotherapy

Sexual Dimorphism of Immune Responses: A New Perspective in Cancer Immunotherapy

Nowadays, several types of tumors can benefit from the new frontier of immunotherapy, due to the recent increasing knowledge of the role of the immune system in cancer control. Among the new therapeutic strategies, there is the immune checkpoint blockade (ICB), able to restore an efficacious antitum...

Full description

Bibliographic Details
Main Authors:	Imerio Capone, Paolo Marchetti, Paolo Antonio Ascierto, Walter Malorni, Lucia Gabriele
Format:	Article
Language:	English
Published:	Frontiers Media S.A. 2018-03-01
Series:	Frontiers in Immunology
Subjects:	cancer immunotherapy sexual dimorphism interferon immune response immune checkpoint inhibitors
Online Access:	http://journal.frontiersin.org/article/10.3389/fimmu.2018.00552/full

Similar Items

Downregulating testosterone levels enhance immunotherapy efficiency
by: Luoyang Wang, et al.
Published: (2021-01-01)

Therapeutic Advancements Across Clinical Stages in Melanoma, With a Focus on Targeted Immunotherapy
by: Claudia Trojaniello, et al.
Published: (2021-06-01)

Sexual conflict drives micro- and macroevolution of sexual dimorphism in immunity
by: Basabi Bagchi, et al.
Published: (2021-06-01)

Immune Checkpoint Expression on Immune Cells of HNSCC Patients and Modulation by Chemo- and Immunotherapy
by: Lisa K. Puntigam, et al.
Published: (2020-07-01)

Immunotherapy for Uterine Cervical Cancer
by: Masahiro Kagabu, et al.
Published: (2019-09-01)

The Role of Immunotherapy in the Treatment of Adrenocortical Carcinoma
by: Izabela Karwacka, et al.
Published: (2021-01-01)

Activating cGAS-STING pathway for the optimal effect of cancer immunotherapy
by: Anping Li, et al.
Published: (2019-04-01)

Identifying baseline immune-related biomarkers to predict clinical outcome of immunotherapy
by: Sacha Gnjatic, et al.
Published: (2017-05-01)

Cryoablation and immunotherapy: an overview of evidence on its synergy
by: B. M. Aarts, et al.
Published: (2019-05-01)

Towards the era of immune checkpoint inhibitors and personalized cancer immunotherapy
by: Hiromichi Nakajima, et al.
Published: (2021-01-01)

New Immune Checkpoint: Advances in Immunotherapy for Malignant Tumors
by: YANG Changliang, et al.
Published: (2018-12-01)

Developments in Immunotherapy for Advanced Non-small Cell Lung Cancer
by: Haoyang LI, et al.
Published: (2021-02-01)

Incorporating Radiation Oncology into Immunotherapy: proceedings from the ASTRO-SITC-NCI immunotherapy workshop
by: Ariel E. Marciscano, et al.
Published: (2018-01-01)

Immunotherapy in patients with cervical cancer
by: A. G. Kedrova
Published: (2020-11-01)

Challenges to Successful Implementation of the Immune Checkpoint Inhibitors for Treatment of Glioblastoma
by: Stephanie Sanders, et al.
Published: (2020-04-01)

Immune landscape of inflammatory breast cancer suggests vulnerability to immune checkpoint inhibitors
by: François Bertucci, et al.
Published: (2021-01-01)

Immunotherapy and associated immune-related adverse events at a large UK centre: a mixed methods study
by: Liz Jamieson, et al.
Published: (2020-08-01)

The Role of Antigen Processing and Presentation in Cancer and the Efficacy of Immune Checkpoint Inhibitor Immunotherapy
by: Anastasia Mpakali, et al.
Published: (2021-01-01)

Tumor matrix remodeling and novel immunotherapies: the promise of matrix-derived immune biomarkers
by: Muhammad Umair Mushtaq, et al.
Published: (2018-07-01)

Immunotherapy in cholangiocarcinoma: From concept to clinical trials
by: Wen-Yan Yao, et al.
Published: (2021-06-01)

VISTA: A Promising Target for Cancer Immunotherapy?
by: Tagliamento M, et al.
Published: (2021-06-01)

Immune Therapy Resistance and Immune Escape of Tumors
by: Barbara Seliger, et al.
Published: (2021-02-01)

Immune oncology, immune responsiveness and the theory of everything
by: Tolga Turan, et al.
Published: (2018-06-01)

The Role of Immunotherapy in a Tolerogenic Environment: Current and Future Perspectives for Hepatocellular Carcinoma
by: Liliana Montella, et al.
Published: (2021-07-01)

Immune checkpoint inhibitors: An innovation in immunotherapy for the treatment and management of patients with cancer
by: Jennifer Dine, et al.
Published: (2017-01-01)

HLA-G/ILTs Targeted Solid Cancer Immunotherapy: Opportunities and Challenges
by: Aifen Lin, et al.
Published: (2021-06-01)

TREM2: Keeping Pace With Immune Checkpoint Inhibitors in Cancer Immunotherapy
by: Hui Qiu, et al.
Published: (2021-09-01)

Clinical diagnosis and treatment of immune checkpoint inhibitor‐associated pneumonitis
by: Hanping Wang, et al.
Published: (2020-01-01)

Failure of Immunotherapy—The Molecular and Immunological Origin of Immunotherapy Resistance in Lung Cancer
by: Justyna Błach, et al.
Published: (2021-08-01)

Immunotherapy for Uterine Cervical Cancer Using Checkpoint Inhibitors: Future Directions
by: Masahiro Kagabu, et al.
Published: (2020-03-01)

Clinical Diagnosis and Treatment Recommendations for the Pneumonitis Associated with Immune Checkpoint Inhibitor
by: Hanping WANG, et al.
Published: (2019-10-01)

Predictive biomarkers for tumor immune checkpoint blockade
by: Tong M, et al.
Published: (2018-10-01)

The Role of Immune Checkpoint Inhibitors in Classical Hodgkin Lymphoma
by: Nicholas Meti, et al.
Published: (2018-06-01)

Research Progress of Immune Checkpoint Therapy on Colorectal Cancer
by: CAO Qihua, et al.
Published: (2021-03-01)

Combination Cancer Immunotherapy of Nanoparticle-Based Immunogenic Cell Death Inducers and Immune Checkpoint Inhibitors
by: Qi J, et al.
Published: (2021-02-01)

Combinatorial Approaches With Checkpoint Inhibitors to Enhance Anti-tumor Immunity
by: Barbara Seliger
Published: (2019-05-01)

Modern Aspects of Immunotherapy with Checkpoint Inhibitors in Melanoma
by: Vera Petrova, et al.
Published: (2020-03-01)

Novel immunotherapy in metastatic renal cell carcinoma
by: Yang Hyun Cho, et al.
Published: (2017-07-01)

The Mechanism of Stimulating and Mobilizing the Immune System Enhancing the Anti-Tumor Immunity
by: Zhengguo Wu, et al.
Published: (2021-06-01)

Reverting Immune Suppression to Enhance Cancer Immunotherapy
by: Bella S. Guerrouahen, et al.
Published: (2020-01-01)